# A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease

> **NCT00731172** · PHASE2 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Crohns Disease

## Interventions

- **DRUG:** glatiramer acetate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00731172
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2010-07
- **Final completion:** 2011-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00731172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00731172, "A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00731172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*